Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Addex Therapeutics Ltd. Sponsored ADR (ADXN) had Receiveable Turnover of 3.41 for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
$1.49M |
|
$-21.80M |
|
-- |
|
$1.49M |
|
$22.99M |
|
$-21.50M |
|
$-0.30M |
|
$-21.80M |
|
$-21.80M |
|
$-21.80M |
|
$-21.80M |
|
$-21.80M |
|
$-21.80M |
|
$-21.50M |
|
$-21.16M |
|
0.38M |
|
0.38M |
|
$-57.84 |
|
$-57.84 |
|
| Balance Sheet Financials | |
$8.20M |
|
$0.04M |
|
$0.47M |
|
$8.68M |
|
$3.44M |
|
-- |
|
$0.09M |
|
$3.53M |
|
$5.15M |
|
$5.15M |
|
$5.15M |
|
0.50M |
|
| Cash Flow Statement Financials | |
$-17.22M |
|
$0.00M |
|
$3.25M |
|
$21.47M |
|
$7.29M |
|
$-14.18M |
|
$3.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1442.61% |
|
-1442.61% |
|
-1419.89% |
|
-1462.57% |
|
-1462.57% |
|
$-17.23M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
-- |
|
|
Receiveable Turnover |
3.41 |
106.97 |
|
-423.46% |
|
-423.46% |
|
-251.20% |
|
-423.46% |
|
$10.35 |
|
$-45.75 |
|
$-45.74 |
|